World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
71
Citations
23959
World Ranking
1350
National Ranking
683

Yang Xu publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Yang Xu sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 220 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Yang Xu D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Yang Xu sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 71 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Yang Xu is a researcher affiliated with the University of California, San Diego in the United States, whose work spans multiple areas in biochemistry, genetics, molecular biology, and medicine. Their research publications reflect a significant focus on molecular biology and cancer-related subjects, with an emphasis on mechanisms at the genetic and molecular level.

Their main fields of study include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these broader fields, the primary subfields of study Yang Xu has contributed to are:

  • Molecular Biology
  • Cancer Research
  • Economics and Econometrics
  • Oncology
  • Genetics

The topics most frequently addressed in their research consist of:

  • Energy, Environment, Economic Growth
  • Cancer-related molecular mechanisms research
  • MicroRNA in disease regulation
  • RNA modifications and cancer
  • Ubiquitin and proteasome pathways
  • Circular RNAs in diseases
  • Cancer, Hypoxia, and Metabolism

Yang Xu has published extensively in several scientific journals. The most frequent publication venues include:

  • Frontiers in Oncology
  • Blood
  • Environmental Science and Pollution Research
  • Resources Policy
  • Frontiers in Immunology

Some notable recent papers authored or co-authored by Yang Xu comprise:

  • "Mutant p53 in Cancer Progression and Targeted Therapies," 2020, Frontiers in Oncology
  • "Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics," 2020, Cell
  • "Natural resource consumption and industrial green transformation: Does the digital economy matter?," 2023, Resources Policy
  • "Climate policy uncertainty and corporate green innovation: Evidence from Chinese A-share listed industrial corporations," 2023, Energy Economics
  • "MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing," 2020, Nature Communications

Frequent collaborators in Yang Xu's research efforts include:

  • Qiying Ran
  • Xiaodong Yang
  • Wenyu Cao
  • Kaiyuan Ji
  • Wenfeng Ge

Best Publications

  • AMP-Activated Protein Kinase Induces a p53-Dependent Metabolic Checkpoint

    Russell G. Jones;David R. Plas;Sara Kubek;Monica Buzzai

  • Immunogenicity of Induced Pluripotent Stem Cells

    Tongbiao Zhao;Zhen-Ning Zhang;Zhili Rong;Yang Xu

  • p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression

    Tongxiang Lin;Connie Chao;Shin'ichi Saito;Sharlyn J. Mazur

  • Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.

    Y Xu;T Ashley;E E Brainerd;R T Bronson

  • Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development.

    Forbes D. Porter;John Drago;Yang Xu;Surindar S. Cheema

  • Dual roles of ATM in the cellular response to radiation and in cell growth control.

    Y Xu;D Baltimore

  • p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM

    Hoseok Song;Monica Hollstein;Monica Hollstein;Yang Xu

  • Direct 3D bioprinting of prevascularized tissue constructs with complex microarchitecture.

    Wei Zhu;Xin Qu;Jie Zhu;Xuanyi Ma

  • Involvement of receptor-interacting protein 2 in innate and adaptive immune responses

    Arnold I. Chin;Paul W. Dempsey;Kevin Bruhn;Jeff F. Miller

  • p53, oxidative stress, and aging.

    Dongping Liu;Yang Xu

  • Radiation-induced Assembly of Rad51 and Rad52 Recombination Complex Requires ATM and c-Abl

    Gang Chen;Shyng Shiou F. Yuan;Wei Liu;Yang Xu

  • Targeted Disruption of TRAF3 Leads to Postnatal Lethality and Defective T-Dependent Immune Responses

    Yang Xu;Genhong Cheng;David Baltimore

  • Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.

    Lijin Feng;Tongxiang Lin;Hiroaki Uranishi;Wei Gu

  • B cell development in mice that lack one or both immunoglobulin kappa light chain genes.

    Jianzhu Chen;M. Trounstine;C. Kurahara;F. Young

  • p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage.

    Connie Chao;Shin'ichi Saito;Jian Kang;Carl W. Anderson

  • Phosphorylation site interdependence of human p53 post-translational modifications in response to stress.

    Shin'ichi Saito;Hiroshi Yamaguchi;Yuichiro Higashimoto;Connie Chao

  • An Effective Approach to Prevent Immune Rejection of Human ESC-Derived Allografts

    Zhili Rong;Meiyan Wang;Meiyan Wang;Zheng Hu;Martin Stradner

  • Deletion of the Igκ Light Chain Intronic Enhancer/Matrix Attachment Region Impairs but Does Not Abolish VκJκ Rearrangement

    Yang Xu;Laurie Davidson;Frederick W Alt;David Baltimore

  • LH-2: a LIM/homeodomain gene expressed in developing lymphocytes and neural cells

    Yang Xu;Mark Baldassare;Peter Fisher;Gary Rathbun

  • A common Gain of function of p53 cancer mutants in inducing genetic instability

    Dong-ping Liu;Hoseok Song;Yang Xu

Frequent Co-Authors

David Baltimore
David Baltimore California Institute of Technology
Frederick W. Alt
Frederick W. Alt Boston Children's Hospital
Ettore Appella
Ettore Appella National Institutes of Health
Monica Hollstein
Monica Hollstein University of Leeds
Carl W. Anderson
Carl W. Anderson Brookhaven National Laboratory
Yong-Guang Yang
Yong-Guang Yang Jilin University
Martin Friedlander
Martin Friedlander Scripps Research Institute
Wei Wang
Wei Wang University of California, San Diego
David J. Chen
David J. Chen The University of Texas Southwestern Medical Center
Eva Y.-H. P. Lee
Eva Y.-H. P. Lee University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Molecular Biology can open the door to a wide range of online educational and career opportunities in the broader health sciences field. For those interested in combining science with communication, asha certified slp programs offer flexible, accredited pathways to becoming a speech-language pathologist. These programs are designed to meet industry standards and provide specialized clinical knowledge.

If you have an undergraduate background in a different area, speech pathology bridge programs can help bridge the gap, enabling you to qualify for advanced graduate studies or licensure. For those considering a transition into nursing, online absn programs for non nurses provide an accelerated path to a nursing degree, even if your bachelor’s is in a different field.

Additionally, career options such as psychiatric nurse practitioner roles are growing quickly. It’s important to consider earning potential when planning your future—review the psych np salary by state to gauge expectations in this high-demand career. Each of these pathways leverages a scientific background, offering rewarding opportunities both in and out of traditional biology roles.

Best Scientists Citing Yang Xu

Trending Scientists

Recently Published Articles